Title:
ＦＧＦＲ選択的チロシンキナーゼ阻害剤を含む医薬組成物
Document Type and Number:
Japanese Patent JP2020536846
Kind Code:
A
Abstract:
本発明は、ＦＧＦＲ選択的チロシンキナーゼ阻害剤、具体的には５−（（２−（４−（１−（２−ヒドロキシエチル）ピペリジン−４−イル）ベンズアミド）ピリジン−４−イル）オキシ）−６−（２−メトキシエトキシ）−Ｎ−メチル−１Ｈ−インドール−１−カルボキサミド又はその薬学的に許容できる塩を含む医薬組成物を提供する。【選択図】図３
Inventors:
Tatsuya Sasaki
Kenichi Saito
Kenichi Saito
Application Number:
JP2020512051A
Publication Date:
December 17, 2020
Filing Date:
October 10, 2018
Export Citation:
Assignee:
Eisai R & D Management Co., Ltd.
International Classes:
A61K31/4545; A61P35/00; A61P43/00
Foreign References:
| WO2014129477A1 | 2014-08-28 | |||
| WO2016152907A1 | 2016-09-29 | |||
| WO2017104739A1 | 2017-06-22 |
Other References:
MOLECULAR CANCER THERAPEUTICS, vol. 15, no. 11, JPN6022038095, 2016, pages 2630 - 2639, ISSN: 0005006226
CLINICALTRIALS.GOV ARCHIVE, NCT02275910, JPN6022038096, June 2017 (2017-06-01), ISSN: 0005006227
CLINICALTRIALS.GOV ARCHIVE, NCT02275910, JPN6022038096, June 2017 (2017-06-01), ISSN: 0005006227
Attorney, Agent or Firm:
Yoshiki Hasegawa
Yoshinori Shimizu
Kimoto
Yoshinori Shimizu
Kimoto